Chromosome 20p13-p12.3 Deletion: Evaluation and Management
Initial Diagnostic Confirmation
Chromosomal microarray analysis (CMA) is the recommended first-line diagnostic test to confirm and precisely characterize the 20p13-p12.3 deletion, including exact breakpoints and deletion size 1. CMA provides superior resolution compared to conventional karyotyping and identifies the specific genes involved, which is critical for phenotype prediction and genetic counseling 2.
Parental Testing
- Always perform parental chromosomal studies (CMA or FISH) even if both parents appear phenotypically normal 3
- This determines if the deletion is de novo (most common) or inherited
- Identifies potential parental mosaicism that affects recurrence risk
- Provides essential information for genetic counseling regarding future pregnancies
Consider Additional Genetic Testing
If atypical features are present beyond the expected 20p deletion phenotype, consider exome or genome sequencing to identify potential pathogenic variants on the remaining allele that could unmask autosomal recessive conditions 3.
Comprehensive Clinical Evaluation at Diagnosis
Cardiac Assessment
- Echocardiogram and EKG immediately at diagnosis 3
- Congenital heart defects (particularly ventricular septal defects) have been reported in 20p deletions 4
- Establish baseline for long-term cardiac surveillance
Growth and Endocrine Evaluation
- Measure height, weight, and growth velocity - short stature is present in 50% of reported 20p13 deletion cases 5
- Baseline endocrine panel: calcium, magnesium, PTH, TSH, free T4, IGF-1 3
- Growth hormone studies if growth faltering is present 6
- Monitor for hypoglycemia and metabolic acidosis 6
Neurological and Developmental Assessment
- Comprehensive developmental evaluation documenting motor, speech, and cognitive milestones 3
- Neurological examination with attention to seizure history 6
- Consider neuroimaging (MRI) if seizures or focal neurological findings present
- Baseline EEG if seizure disorder suspected
Dysmorphology Examination
Document specific features commonly associated with 20p deletions:
- Facial features: malar hypoplasia, high arched palate, microstomia, long philtrum, proptosis, retrognathia 6
- Cleft palate or submucous cleft palate 7
- Assess for skeletal abnormalities
Additional Organ System Evaluation
- Renal and bladder ultrasound - genitourinary anomalies reported 4
- Gastrointestinal assessment - anorectal malformations and megacolon documented 4
- Ophthalmologic examination for refractive errors and structural abnormalities 3
- Audiology evaluation with audiogram 3
- Speech and language assessment - language delay common 5
Psychiatric and Behavioral Screening
- Baseline psychiatric evaluation - severe neuropsychiatric manifestations including depression with psychotic features have been reported, particularly with CSNK2A1 involvement 8
- Screen for autism spectrum disorder, ADHD, anxiety 9, 3
Genetic Counseling
Provide comprehensive genetic counseling at diagnosis and periodically throughout childhood, particularly in mid-to-late teenage years and before family planning 3.
Key Counseling Points:
- Explain deletion size, specific genes involved, and genotype-phenotype correlations
- Discuss variable expressivity and phenotypic spectrum based on deletion size and gene content
- Provide recurrence risk estimates based on parental testing results
- Discuss reproductive options including prenatal diagnosis and preimplantation genetic testing
- Facilitate information dissemination to at-risk relatives 10
Ongoing Management and Surveillance
Annual/Biennial Monitoring
- Growth parameters and nutritional assessment 3
- Endocrine function: calcium, thyroid, growth hormone axis 3
- Developmental and cognitive assessments with standardized measures 3
- Cardiac surveillance if congenital heart disease present 3
- Hearing evaluation 3
- Psychiatric and behavioral assessment - particularly important given reported severe psychiatric manifestations 8
Multidisciplinary Coordination
Establish care with a clinician experienced in chromosomal deletion syndromes who can coordinate subspecialty evaluations 3. This is essential given the multisystem involvement and variable phenotype.
Educational and Developmental Support
- Early intervention services for developmental delays
- Individualized education plan (IEP) for learning disabilities
- Speech therapy for language delays
- Physical and occupational therapy as needed
Critical Management Considerations
Avoid Common Pitfalls:
- Do not assume normal function in any organ system without baseline evaluation - phenotypic variability is significant 6, 5
- Do not skip parental testing - even phenotypically normal parents may carry the deletion or have mosaicism 3
- Do not overlook psychiatric manifestations - severe depression and psychosis have been reported and require proactive screening 8
Specific to 20p Deletions:
The phenotypic spectrum varies significantly based on deletion size and specific genes involved. Deletions encompassing CSNK2A1 may present with Okur-Chung neurodevelopmental syndrome features including intellectual disability and neuropsychiatric symptoms 8. Deletions involving JAG1 may manifest Alagille syndrome features including cardiac, hepatic, and skeletal abnormalities 11.